Health
Mak Launches Homegrown COVID-19 Rapid Antibody Test Kits
Published
6 years agoon

By: Harriet Adong, Mak-RIF Communications Officer
The afternoon of Wednesday March 17th, 2021 saw Makerere University’s Department of Immunology and Molecular Biology, College of Health Sciences (CHS) launch the homegrown COVID-19 Rapid Antibody Test Kits. The COVID-19 Rapid Antibody Test Kits developed domestically aim to address challenges related to affordability/cost using imported items, promote research and innovation in the medical/health field and Makerere University in general.
This project was spearheaded by Dr. Misaki Wayengera, Director Biomedical Research at the Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University. Dr. Wayengera is also the Chairperson of the Scientific Advisory Committee on the COVID-19 Taskforce in the Ministry of Health. These efforts are directed towards enhancing the fight against the spread of the Corona Virus not only at Makerere University but also in the entire country. Explaining the advantages of the project, Dr. Wayengera said “Makerere University has developed an affordable (costing less than US $1), easy to use (requiring minimal expertise, user guide), rapid (yielding results within 2-5 minutes) point of care test platform for COVID-19 suited for use within remote equatorial African settings. This will enable rapid testing for Coronavirus and considerably lower the cost of testing currently standing at USD 65, which is prohibitive for developing countries like Uganda. This could not have been achieved without the financial support of Partners and Institutions such as Supervised Financial Institutions under their umbrella body Uganda Bankers Association, Deposit Protection Fund of Uganda, and Government of the Republic of Uganda, the French Embassy in Uganda and Uganda’s Ministry of Science Technology and Innovation’’.
The Test Kit involves using a swab-tube dipstick to do an antigen test by use of a nasal sample. With this quick test, once the nasopharyngeal sample is obtained, it is placed back into its tube containing reagents that detect the virus surface protein.

This event was attended by Uganda’s Minister of Health; Hon. Dr. Jane Ruth Aceng Ocero, Uganda’s Minister of Science Technology and Innovation; Hon. Dr. Elioda Tumwesigye, French Ambassador to Uganda; His Excellency Jules-Armand Aniambossou, the World Health Organization Country Representative; Dr. Yonas W. Tegeny, Uganda’s Director General at Ministry of Health; Dr. Henry Mwebesa and the Permanent Secretary at Ministry of Health; Dr. Diana Atwine. The funders were also represented at the event and these included; Makerere University Research and Innovations Fund (Mak-RIF) represented by Dr. Roy William Mayega, Mak-RIF Coordinator, Uganda Bankers Association represented by Mr. Wilbrod Owor, the French Embassy and Ministry of Science Technology and Innovation like earlier listed among other dignitaries.
At the occasion, Prof. Damalie Nakanjako, Principal Makerere University College of Health Sciences represented Makerere University’s Vice Chancellor Prof. Barnabas Nawangwe. She welcomed all scientists, innovators and the media fraternity (representing the community) to witness yet another stride in and by faculty in Uganda’s leading higher institution of learning-Makerere University. In her remarks, she noted that, the University has through College of Health Sciences built extensive expertise, experience and eco-systems across the academia and partnerships for Research and Development of pathogen diagnostic. “This kit will carry out antibody tests. It will also be used in early detection of COVID-19 cases, used in screening of travelers for COVID-19, detection of symptoms as well as aid in sero-prevalennce studies to determine previous exposure to COVID-19. Makerere University is hopeful that this will enable Uganda and other African countries to cost-effectively respond to the COVID-19 pandemic”.
Makerere University is grateful for the SEED funding (UGX 65, 527, 020) from the Government of the Republic of Uganda through Makerere University Research and Innovations Fund (Mak-RIF) which aided initialization of this project. The Government of the Republic of Uganda is funding cross disciplinary research and innovations (over 500 projects now, up to a tune of Uganda Shillings 60 billion only for the last two financial years). Makerere University faculty and students have through this initiative engaged with other institutions, organizations, disciplines and Ministries enhancing research and innovations in and outside the institution. For all this support, we are truly grateful to the Government of the Republic of Uganda and all our other funders/partners, Prof. Nakanjako added.

Hon. Dr. Elioda Tuwesigye, Minister of Science Technology and Innovation in Uganda noted that such strides like the launch of Makerere University homegrown COVID-19 Rapid Antibody Test Kits was only a wake-up call to all of us that the virus is still with us and we can together do so much to up the fight against further spread and effects. He thanked the Government of the Republic of Uganda for funding research and innovations in Makerere University and other institutions too. “It is through research that we garner additional knowledge to enable us to be and remain creative. Embracing Research and Innovation is the way to go if we are to realize development in our country, Africa and the globe’’, he added.
Uganda’s Minister of Health at the event in her remarks congratulated all scientists at Makerere University including Dr. Wayengera and his research for working closely with the Ministry to respond to diverse community challenges and in this case the Coronavirus. She noted that this virus is still with us and thus the need for us to continue observing the Standard Operating Procedures, researching ad innovating to carry on with the fight. She added that some countries were experiencing the second and third wave of Coronavirus and thus Ugandans must remain on the alert regardless of the circumstances at the moment so that these waves do not crop in and sweep away the population. Hon. Dr. Aceng said: “These rapid antibody testing kits come at a point when we are preparing for the next wave of the COVID-19 pandemic, thank you Dr. Wayengera and team.’’
His Excellency Jules-Armand Aniambossou, French Ambassador in his remarks noted that the French Embassy in Uganda was and is happy to collaborate with and further support Makerere University’s efforts to respond to the Coronavirus. He said “Uganda’s response to COVID-19 was and is strong, immediate ad efficient. We need to learn from Uganda. Uganda can compete globally. Well done Scientists, he said as he officially launched the homegrown COVID-19 Rapid antibody Test Kits’’.

In the drive to raise funds towards the fight against the COVID-19 pandemic, and in response to Government’s call for support to join hands, Members of Uganda Bankers Association (UBA) and the Deposit Protection Fund contributed UGX. 200million to the project which was in advanced stages in 2020. Speaking at the occasion, Mr. Wilbrod Owor-Executive Director UBA applauded Makerere University for the research efforts as an academic institution and the quick turnaround invention. “The pandemic has had diverse effects on the economy and one of the most affected sectors are education, tourism & hospitality, real estate which ultimately have affected the banking sector by way of increase in Non-Performing Loans. In addition to the loan restructures that member banks have offered, as part of support to business community, we are also happy to have invested to support testing. Therefore, the affordability of this intervention is much welcome to address cost issues that would otherwise have to be so high for an average Ugandan” Owor said.
Dr. Roy William Mayega, Coordinator at the Makerere University Research and Innovations Fund (Mak-RIF) on behalf of Prof. William Bazeyo, Chair Mak-RIF thanked Dr. Wayengera and his research/innovation team for the work well done. He also thanked all funders for positively responding to the call for more resources to realize this project. He said “It is only when funders see such research and innovation outputs like the COVID-19 Rapid antibody Test Kits we are holding in our hands now that they will look further into their Bank Accounts to raise more resources to further support research and innovations. Thank you Dr. Wayengera and all the other Scientists for leading by doing. Let us continue with these efforts’’.
Dr. Wayengera acknowledged all the support/funding and gave each donor a pack of the COVID-19 Rapid Antibody Testing Kits.

The event host, Prof. Nakanjako, Principal at Makerere University’s College of Health Sciences then thanked all participants and welcomed them to further engage in a cocktail as volunteers led by the Director General and Minister of Health experienced antibody testing using the newly launched kits. The rest of the COVID-19 Test Kits will be used in the Makerere University Medical School laboratories
Congratulations Makerere University and congratulations the Government of the Republic of Uganda!
‘We Build for the Future, For God and My Country’
View and read about this launch in the Media
- New COVID-19 rapid antibody test kits launched to reduce cost and promote research. – https://joripress.com/new-covid-19-rapid-antibody-test-kits-launched-to-reduce-cost-and-promote-research
- https://www.ntv.co.ug/ug/news/national/local-testing-ability-improves-with-new-covid-19-kits-3326454
- https://chimpreports.com/makerere-launches-own-covid19-testing-kit/
- https://www.independent.co.ug/makerere-university-launches-covid-19-anti-body-test-kits/
- https://twitter.com/JaneRuth_Aceng/status/1372187357781360642?s=1002
- https://www.monitor.co.ug/uganda/news/national/scientists-behind-uganda-s-first-coronavirus-test-kits-3327390
- New Vision Newspaper Friday March 19th , 2021, Page 10
- Daily Monitor Newspaper Thursday March 18th , 2021 Page 6
You may like
-
Uganda’s HIV Treatment Gains Bring the Youth Gap into Focus
-
Mak, CoRE-MATH Project Partners Develop Models to Address Regional Development Challenges
-
MakSPH reseachers calls for health data to be used in decisions
-
UPHIA 2025 Shows Uganda’s HIV Status Awareness Gap Despite Strong Treatment Outcomes
-
2nd National Inter University Debate Competition 2026 Makerere Secures 2nd Place
-
Call for Applications: RLRH Graduate Traineeship Programme
Health
Uganda’s HIV Treatment Gains Bring the Youth Gap into Focus
Published
2 days agoon
October 5, 2026
Uganda’s latest national HIV survey reveals lower viral suppression among adolescents and young adults living with HIV than among older adults, even as the country records substantial improvements in controlling the virus. The findings come from Uganda Population-Based HIV Impact Assessment (UPHIA 2025), a national household survey examining HIV prevalence and whether people living with the virus know their status, receive treatment, and achieve viral suppression.
Releasing the preliminary UPHIA 2025 findings at the Uganda Media Centre on 1 October 2026, Minister of Health Hon. Dr. Chris Baryomunsi called for earlier prevention and testing, particularly among adolescent girls and young women, alongside support for treatment adherence. “We must reach out to the young people, ensure that they have information, they test, take treatment, and adhere to the treatment guidance,” he urged.
Hon. Baryomunsi recalled how fear had discouraged testing during his university years: “I remember when we were at university, we went for testing at the university hospital. We sat there for three hours. Some of us left without even testing because it was scary.” Today, he explained, “even if you test HIV positive, you can be initiated on treatment, and you live normally like the rest of those who don’t have HIV.”

UPHIA 2025 was locally led under the Ministry of Health’s overall leadership, with Makerere University School of Public Health serving as the prime implementer, a role ICAP at Columbia University held in the previous two surveys. The Uganda Bureau of Statistics led sampling, while the Uganda Virus Research Institute and National Health Laboratory and Diagnostic Services led laboratory operations. Regional referral hospitals and local governments supported implementation, and the U.S. government provided US$10 million through PEPFAR, along with technical assistance from the U.S. CDC.
UPHIA collected data from July to September 2025 among people aged 15 and above, including those outside routine treatment services. Of 6,283 eligible households, 94.4% completed interviews. Researchers interviewed 13,801 people and tested 13,477 for HIV.
Testing followed Uganda’s national algorithm, with laboratory confirmation of positive samples, viral-load measurement, and checks for antiretroviral medicines to establish treatment use. Researchers weighted the estimates to account for the sampling design. Participants received counselling and results, and those who tested positive were referred for treatment.
Hon. Baryomunsi thanked participants and their families for welcoming survey staff and contributing their time, information and samples, without which the national evidence would not have been available.

National progress and the youth gap
The survey estimated HIV prevalence, which means the proportion of people living with HIV, at 5.9% among those aged 15 and above, corresponding to about 1.496 million people in this age group nationwide. Prevalence was 7.3% among women and 4.1% among men, ranging from 1.3% in Karamoja to 8% in the South Western region.
Among people aged 15 and above living with HIV, 86% had achieved viral suppression, meaning a low amount of HIV in the blood, measured in UPHIA as fewer than 1,000 copies per millilitre. Suppression stood at 69.3% among adolescents and young adults aged 15–24 living with HIV, compared with 89.9% among those aged 50 and above. These estimates cover people living with HIV regardless of whether they know their status or receive treatment.

HIV prevalence among people aged 15–24 was 1.5%, including 2% among young women and 1% among young men. Among young women, prevalence was 1.3% at ages 15–19 and 2.8% at ages 20–24. These differences support attention to earlier prevention and testing, although they do not establish when infections occurred.
The highest prevalence estimates occurred among middle-aged adults: 15.7% among women aged 40–44 and 11.7% among men aged 45–49. Lower suppression among young people therefore requires attention alongside the higher HIV prevalence among middle-aged adults. Comparing the same age group across both surveys, viral suppression among people aged 15–64 increased from 74.9% in 2020–21 to 86.1% in 2025, while HIV prevalence remained at 5.9%.

Diagnosis and the path to 2030
The treatment results identify diagnosis as the main national gap. Among people aged 15 and above living with HIV, 85.3% knew their status. Of those aware, 99.1% were receiving treatment; among those receiving treatment, 96.5% had achieved suppression.
The 95-95-95 targets aimed for 95% of people living with HIV to know their status, 95% of those diagnosed to receive treatment, and 95% of those receiving treatment to achieve viral suppression by 2025. Among people aged 15 and above, Uganda exceeded the treatment and suppression targets, while diagnosis remained below target. UNAIDS’s Global AIDS Strategy 2026–2031 retains these targets towards ending AIDS as a public health threat by 2030.
According to WHO, viral suppression protects health and helps prevent HIV transmission. Uncontrolled HIV weakens the immune system, increasing the risk of serious illness. With continued treatment as prescribed, sexual transmission risk is negligible when HIV remains suppressed but detectable, and zero when undetectable. The Uganda AIDS Commission estimated over 34,000 new HIV infections in 2025, underscoring the importance of early diagnosis, timely treatment, and sustained suppression alongside other prevention measures.

The demographic stakes are substantial. People aged 15–24 constituted 21.2% of Uganda’s population in the 2024 census. The country’s Fourth National Development Plan, covering 2025–2030, prioritises a healthy, knowledgeable, skilled and productive population and reducing HIV through primary health care. Protecting young people’s health, therefore, supports their participation in education, work, and national development; UPHIA helps identify where services need greater attention.
Turning evidence into action
The study’s conclusions identify three priorities: sustain treatment outcomes, find people unaware of their status, and improve suppression among younger people. Permanent Secretary Dr. Diana Atwine connected the findings to the Ministry’s planning.
“We do believe that these results are a true reflection of what is happening in our country as far as the HIV status is concerned, and we do believe that it will give us a very clear direction and the roadmap that we are going to take in the next five years to target and to get our targets achieved.”

Acting on these priorities requires funding for services and research. Hon. Baryomunsi outlined plans to target resources where needs are greatest, strengthen district services and align partner support with government priorities. Responding to journalists’ questions, he noted the government’s intention to increase domestic funding for the HIV response, including research.
“The HIV/AIDS response, including research and surveys such as this one, has largely been funded by partners in the past. The government of Uganda is committed to allocating more resources from our domestic budget to support the response and research,” he noted.
For the first time in the UPHIA series, the survey assessed selected noncommunicable disease indicators among people aged 15 and above: 15.5% had elevated blood pressure, 24.8% were overweight or obese, and 0.9% had raised random blood glucose. These screening findings align with the Ministry’s integration agenda and Hon. Baryomunsi’s call to bring HIV and chronic care services together to address people’s wider health needs.
Speaking at the release of the preliminary results, U.S. Embassy Chargé d’Affaires Mikael (Mika) Cleverley described UPHIA 2025 as the first Population-Based HIV Impact Assessment worldwide fully led and implemented by the country itself.

“The study was led by Ugandan scientists, Ugandan managers, Ugandan public servants, Ugandan field teams, from design to data collection to analysis. And this is what two decades of focused strategic U.S. foreign investments in the public health sector was meant to produce, is to reinforce Ugandan leadership and Ugandan-led efforts.”
At the survey launch on 29 May 2025, MakSPH Dean Prof. Rhoda Wanyenze highlighted the partnership’s contribution: “The partnership between Makerere University and CDC has not only helped build national capacity in surveillance and epidemiology, but has also strengthened our ability to lead high-quality, large-scale national surveys.”

The Dean added: “After two decades of joint work, we are proud that UPHIA is now a fully Ugandan-led effort. This is critical to the sustainability of the skills and knowledge generation to inform our local response.”
UPHIA 2025 shows how far Uganda’s HIV response has advanced and where gaps remain. As the country works towards ending AIDS as a public health threat by 2030, reaching young people with testing, treatment, and continued care will be essential to extending those gains.

Read the full UPHIA 2025 summary results here:
Health
MakSPH reseachers calls for health data to be used in decisions
Published
5 days agoon
October 2, 2026
Health experts from across Africa have called for stronger use of routine health data in planning, supervision and service delivery, noting that although countries are generating large amounts of health information, much of it is still not being used.
The call came during a webinar hosted by the Makerere University School of Public Health (MakSPH) in partnership with The Global Fund under the theme “From National Dashboards to District Action: Strengthening Subnational Data Use for Planning, Supervision and Service Delivery.”
The webinar brought together health information specialists, policymakers and practitioners from Uganda, Kenya, Zimbabwe and Ethiopia to share experiences and lessons on using subnational data for evidence based decision making.
Kenya’s journey from data collection to action
In her keynote address, Dr Helen Kiarie, Head of the Monitoring and Evaluation Division at Kenya’s Ministry of Health, urged health practitioners and policymakers to move beyond routine reporting and use data to improve health outcomes.
“The bottleneck is no longer collecting data. It is turning routine data into decisions and decisions into action,” Dr Kiarie said.
Drawing on Kenya’s experience, she pointed to the country’s shift from paper based reporting systems to digital platforms, noting that more than 95% of public health facilities have been digitised.
According to Dr Kiarie, Kenya has developed National Data Analytics Guidelines to support evidence based decision making across the health system. The guidelines set out a structured approach to data analysis, interpretation and dissemination so that the information generated can be used.
She said building a culture of data use requires leadership that asks for evidence, regular performance reviews, public dashboards, mentorship programmes, and the integration of data into planning and budgeting.
Community data improving maternal health
Dr Kiarie gave practical examples of how data can shape health outcomes.
In Kwale County, community health promoters used household level data to identify and follow up pregnant women, encouraging them to attend antenatal care services and deliver at health facilities.
As a result, skilled birth attendance increased from 50 per cent in 2022 to 85 per cent, while reported home deliveries fell from 808 to 248.
She also pointed to Kenya’s efforts to link digital health data with health financing systems, saying better documentation and data quality have strengthened accountability and increased reimbursements to health facilities.
She added that real time maternal and perinatal death surveillance systems are helping health authorities identify gaps in care, assign responsibility and take corrective action to prevent avoidable deaths.
“Data has moved beyond documenting losses to becoming an instrument for preventing the next avoidable death,” Dr Kiarie said.
Addressing data quality challenges
Despite major investments in digital health systems, Dr Kiarie acknowledged that data quality challenges remain.
She cited system downtimes, the parallel use of paper and digital records, limited access to some digital platforms, and resistance to change among some health workers as barriers to data quality and use.
Still, she said Kenya’s data quality has improved considerably through digitisation and continued investment in governance, analytics capacity and quality assurance.
Regional experiences and lessons
The webinar also included a panel discussion with experts from Uganda, Zimbabwe and Ethiopia, who shared experiences on strengthening data use at district and facility level.
The discussion pointed to the importance of strong leadership, timely information, digital infrastructure and feedback mechanisms that help health workers and managers make informed decisions with the data available.
Participants agreed that health information systems should do more than serve as reporting tools. They should also support decision making where services are delivered.
Moving from information to impact
Speaking during the webinar, Prof. Rhoda Wanyenze, Dean of Makerere University School of Public Health (MAKSPH), commended countries for progress in strengthening health information systems and encouraging data use.
She urged practitioners and researchers to go beyond documenting challenges and start capturing examples of how data informed decisions are improving programmes and health outcomes.
“It would be really good for us to dig deeper in terms of what decisions we have actually made and what we would not have known or done differently if we did not have the data,” she said.
In his closing remarks, Dr Wodimu Ayele of The Global Fund said the value of data lies in its ability to improve service delivery, inform decision making and strengthen accountability.
He called on countries to keep investing in data quality, analytics capacity and health information systems, while making sure evidence generated at all levels leads to measurable improvements in health outcomes.
Health
UPHIA 2025 Shows Uganda’s HIV Status Awareness Gap Despite Strong Treatment Outcomes
Published
6 days agoon
October 1, 2026
Uganda has released the preliminary findings of the 2025 Uganda Population-Based HIV Impact Assessment (UPHIA 2025), a national household survey that provides a current picture of the country’s HIV response and selected non-communicable disease indicators.
At the Uganda Media Centre today, 1 October 2026, the Minister of Health, Hon. Dr Chris Baryomunsi, released the preliminary results and said the evidence would guide policy, resource allocation and service improvement, with particular attention to people and communities with the greatest gaps. He urged Ugandans to know their HIV status, use prevention services and, when diagnosed, start treatment promptly and adhere to it.

Among adults aged 15 years and above, HIV prevalence was 5.9 percent, including 7.3 percent among women and 4.1 percent among men. Among adults aged 15–64, prevalence was also 5.9 percent, unchanged from 2020/21. Across the country, prevalence ranged from 1.3 percent in Karamoja to 8.0 percent in the South Western region. Of adults living with HIV, 85.3 percent knew their status; 99.1 percent of those aware were on treatment; and 96.5 percent of those on treatment had achieved viral load suppression. HIV-status awareness remains the central gap in the 95-95-95 cascade.
The survey also measured selected non-communicable disease indicators for the first time. Elevated blood pressure affected 15.5 percent of adults, while 24.8 percent had overweight or obesity and 0.9 percent had raised blood glucose.

Conducted from July to September 2025, UPHIA 2025 was the first population-based HIV impact assessment to be fully country-led. The Ministry of Health provided overall leadership, while Makerere University School of Public Health served as the prime implementing organisation, working with UVRI, UBOS, regional referral hospitals and local governments. PEPFAR funded the survey through the U.S. CDC.
Watch the UPHIA 2025 preliminary results launch:
https://www.youtube.com/live/QfHFBaJ-L-w
Read the UPHIA 2025 summary results:
https://drive.google.com/file/d/1nElGNwgcAcZyAo9CLCQKRpO2jJgyxjSc/view?usp=drive_link
Trending
-
General2 weeks agoCall for Applications: RLRH Graduate Traineeship Programme
-
General6 days agoStatement on Concerns Circulating Regarding a Member of Academic Staff
-
Research2 weeks agoCall for Makerere Staff PhD Completion Grant Applications, 2026-27
-
Engineering, Art & Tech2 weeks agoPublic Art Talk Sparks Dialogue on Contemporary Art Practices at MTSIFA
-
General1 week agoMakerere Marathon 2026 – Running to Equip the Disability Support Center